Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol
The predominant mechanism of drug resistance in African trypanosomes is decreased drug uptake due to loss-of-function mutations in the genes for the transporters that mediate drug import. The role of transporters as determinants of drug susceptibility is well documented from laboratory-selected Trypanosoma brucei mutants. But clinical isolates, especially of T. b. gambiense, are less amenable to experimental investigation since they do not readily grow in culture without prior adaptation. Here we analyze a selected panel of 16 T. brucei ssp. field isolates that (i) have been adapted to axenic in vitro cultivation and (ii) mostly stem from treatment-refractory cases. For each isolate, we quantify the sensitivity to melarsoprol, pentamidine, and diminazene, and sequence the genomic loci of the transporter genes TbAT1 and TbAQP2. The former encodes the well-characterized aminopurine permease P2 which transports several trypanocides including melarsoprol, pentamidine, and diminazene. We find that diminazene-resistant field isolates of T. b. brucei and T. b. rhodesiense carry the same set of point mutations in TbAT1 that was previously described from lab mutants. Aquaglyceroporin 2 has only recently been identified as a second transporter involved in melarsoprol/pentamidine cross-resistance. Here we describe two different kinds of TbAQP2 mutations found in T. b. gambiense field isolates: simple loss of TbAQP2, or loss of wild-type TbAQP2 allele combined with the formation of a novel type of TbAQP2/3 chimera. The identified mutant T. b. gambiense are 40- to 50-fold less sensitive to pentamidine and 3- to 5-times less sensitive to melarsoprol than the reference isolates. We thus demonstrate for the first time that rearrangements of the TbAQP2/TbAQP3 locus accompanied by TbAQP2 gene loss also occur in the field, and that the T. b. gambiense carrying such mutations correlate with a significantly reduced susceptibility to pentamidine and melarsoprol.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
PLoS neglected tropical diseases - 7(2013), 10 vom: 09., Seite e2475 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Graf, Fabrice E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
673LC5J4LQ |
|---|
| Anmerkungen: |
Date Completed 05.05.2014 Date Revised 29.01.2022 published: Electronic-eCollection GENBANK: KF564925, KF564926, KF564927, KF564928, KF564929, KF564930, KF564931, KF564932, KF564933, KF564934, KF564935, KF564936, KF564937, KF564938, KF564939, KF564940, KF564941, KF564942, KF564943, KF564944, KF564945, KF564946, KF564947, KF564948, KF564949, KF564950, KF564951, KF564952, KF564953, KF564954, KF564955 Citation Status MEDLINE |
|---|
| doi: |
10.1371/journal.pntd.0002475 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM231749228 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM231749228 | ||
| 003 | DE-627 | ||
| 005 | 20231224091450.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pntd.0002475 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0772.xml |
| 035 | |a (DE-627)NLM231749228 | ||
| 035 | |a (NLM)24130910 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Graf, Fabrice E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.05.2014 | ||
| 500 | |a Date Revised 29.01.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a GENBANK: KF564925, KF564926, KF564927, KF564928, KF564929, KF564930, KF564931, KF564932, KF564933, KF564934, KF564935, KF564936, KF564937, KF564938, KF564939, KF564940, KF564941, KF564942, KF564943, KF564944, KF564945, KF564946, KF564947, KF564948, KF564949, KF564950, KF564951, KF564952, KF564953, KF564954, KF564955 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The predominant mechanism of drug resistance in African trypanosomes is decreased drug uptake due to loss-of-function mutations in the genes for the transporters that mediate drug import. The role of transporters as determinants of drug susceptibility is well documented from laboratory-selected Trypanosoma brucei mutants. But clinical isolates, especially of T. b. gambiense, are less amenable to experimental investigation since they do not readily grow in culture without prior adaptation. Here we analyze a selected panel of 16 T. brucei ssp. field isolates that (i) have been adapted to axenic in vitro cultivation and (ii) mostly stem from treatment-refractory cases. For each isolate, we quantify the sensitivity to melarsoprol, pentamidine, and diminazene, and sequence the genomic loci of the transporter genes TbAT1 and TbAQP2. The former encodes the well-characterized aminopurine permease P2 which transports several trypanocides including melarsoprol, pentamidine, and diminazene. We find that diminazene-resistant field isolates of T. b. brucei and T. b. rhodesiense carry the same set of point mutations in TbAT1 that was previously described from lab mutants. Aquaglyceroporin 2 has only recently been identified as a second transporter involved in melarsoprol/pentamidine cross-resistance. Here we describe two different kinds of TbAQP2 mutations found in T. b. gambiense field isolates: simple loss of TbAQP2, or loss of wild-type TbAQP2 allele combined with the formation of a novel type of TbAQP2/3 chimera. The identified mutant T. b. gambiense are 40- to 50-fold less sensitive to pentamidine and 3- to 5-times less sensitive to melarsoprol than the reference isolates. We thus demonstrate for the first time that rearrangements of the TbAQP2/TbAQP3 locus accompanied by TbAQP2 gene loss also occur in the field, and that the T. b. gambiense carrying such mutations correlate with a significantly reduced susceptibility to pentamidine and melarsoprol | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Aquaporin 2 |2 NLM | |
| 650 | 7 | |a DNA, Protozoan |2 NLM | |
| 650 | 7 | |a Protozoan Proteins |2 NLM | |
| 650 | 7 | |a Trypanocidal Agents |2 NLM | |
| 650 | 7 | |a Pentamidine |2 NLM | |
| 650 | 7 | |a 673LC5J4LQ |2 NLM | |
| 650 | 7 | |a Melarsoprol |2 NLM | |
| 650 | 7 | |a ZF3786Q2E8 |2 NLM | |
| 700 | 1 | |a Ludin, Philipp |e verfasserin |4 aut | |
| 700 | 1 | |a Wenzler, Tanja |e verfasserin |4 aut | |
| 700 | 1 | |a Kaiser, Marcel |e verfasserin |4 aut | |
| 700 | 1 | |a Brun, Reto |e verfasserin |4 aut | |
| 700 | 1 | |a Pyana, Patient Pati |e verfasserin |4 aut | |
| 700 | 1 | |a Büscher, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a de Koning, Harry P |e verfasserin |4 aut | |
| 700 | 1 | |a Horn, David |e verfasserin |4 aut | |
| 700 | 1 | |a Mäser, Pascal |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PLoS neglected tropical diseases |d 2007 |g 7(2013), 10 vom: 09., Seite e2475 |w (DE-627)NLM17489287X |x 1935-2735 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2013 |g number:10 |g day:09 |g pages:e2475 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1371/journal.pntd.0002475 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2013 |e 10 |b 09 |h e2475 | ||